Endoscopic Devices - Australia & Oceania

  • Australia & Oceania
  • Revenue in the Endoscopic Devices market market in Australia & Oceania is anticipated to reach US$0.46bn in 2024.
  • The revenue is forecasted to exhibit an annual growth rate (CAGR 2024-2029) of 7.81%, leading to a market volume of US$0.67bn by 2029.
  • In a global context, the highest revenue is expected to be generated the United States, which is projected to reach US$10,390.00m in 2024.
  • In Australia, the increasing demand for minimally invasive surgeries is driving innovation and adoption of advanced endoscopic devices within the medical technology market.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Endoscopic Devices Market in Australia and Oceania is experiencing moderate growth, influenced by factors such as technological advancements, an increase in minimally invasive procedures, and heightened awareness of early diagnosis among healthcare providers and patients.

Customer preferences:
Consumers in Australia and Oceania are showing a growing preference for advanced endoscopic solutions that prioritize comfort and minimal invasiveness, reflecting a cultural shift towards proactive health management. There is an increasing demand for patient-centered care, leading to a rise in the adoption of endoscopic devices that facilitate quicker recovery times and shorter hospital stays. Additionally, as the population ages and health awareness rises, individuals are opting for early diagnostic procedures, pushing healthcare providers to enhance their endoscopic offerings.

Trends in the market:
In Australia and Oceania, the Endoscopic Devices Market is experiencing a surge in demand for minimally invasive procedures, driven by a growing emphasis on patient comfort and quicker recovery times. Healthcare providers are increasingly adopting advanced endoscopic technologies that enhance diagnostic accuracy and reduce hospital stays. As the region's population ages, there is a notable shift towards early detection and preventive care, prompting stakeholders to innovate and expand their endoscopic offerings. This trend signifies a transformation in healthcare delivery, with implications for device manufacturers, healthcare systems, and policymakers alike, as they adapt to a more proactive health management landscape.

Local special circumstances:
In Australia and Oceania, the Endoscopic Devices Market is influenced by the region's unique healthcare landscape, characterized by a robust public healthcare system and a growing private sector. Geographically, vast distances between urban and rural areas necessitate innovative telemedicine solutions that complement endoscopic procedures. Culturally, there is a strong focus on preventive health, leading to increased patient awareness and demand for early diagnostics. Regulatory frameworks are evolving to support faster approval of advanced technologies, enhancing market growth and accessibility for patients across diverse communities.

Underlying macroeconomic factors:
The Endoscopic Devices Market in Australia and Oceania is shaped by macroeconomic factors such as national economic stability, healthcare funding, and demographic trends. A strong economy fosters investment in advanced medical technologies, while government fiscal policies aimed at enhancing healthcare infrastructure further drive market growth. The aging population and rising incidence of chronic diseases create a heightened demand for minimally invasive procedures, increasing the need for innovative endoscopic solutions. Additionally, global economic trends, including supply chain dynamics and international collaborations, play a crucial role in shaping market accessibility and innovation.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)